Ironwood Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Almirall EUR 298.52M 36.18M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amarin USD 162.41M 17.54M 2025-03
Ardelyx USD 81.72M 3.89M 2025-06
Astellas Pharma JPY 1.11T 46.33B 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Charles River Laboratories USD 1.08B 29.38M 2025-06
Exact Sciences USD 521.93M 19.47M 2025-06
Halozyme Therapeutics USD 134.28M 16.1M 2025-06
Incyte USD 1.28B 608.18M 2025-06
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
MacroGenics USD 39M 16.53M 2025-06
Moderna USD 1.57B 32M 2025-06
Myriad Genetics USD 151.1M 13M 2025-03
Pacira USD 313.16M 1.57M 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Takeda JPY 2.17T 336.94B 2025-06
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06


Ironwood Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.